The Rays of Belief IPO has been subscribed 1.5 times by the second day of bidding, driven by strong retail demand. The Rs 125-crore offering is a 100% fresh issue, with funds dedicated to expanding service centres and technology. Investors are now watching the final day of the subscription window on September 3, considering both the growth plans and the company's current negative cash flow status.
The initial public offering (IPO) of Rays of Belief, the parent company of the 'Mom’s Belief' brand, is seeing steady traction during its second day of bidding. As of midday on September 2, 2026, the offering has been subscribed 1.5 times. The demand is heavily concentrated among retail investors, who have bid for more than eight times the shares reserved for their category.
The company has set a price band of Rs 227 to Rs 239 per share for this Rs 125-crore offering. Notably, the entire issue consists of fresh shares, meaning all proceeds will be used by the company for its business growth rather than being pocketed by existing shareholders. Prior to the public opening, the firm secured Rs 50 crore from five institutional investors, including Viney Growth Fund and LRSD Securities, which signals some level of institutional confidence in the company’s expansion model.
Rays of Belief operates in the niche sector of neurodevelopmental disorder intervention. The management has outlined an ambitious capital spending plan. A significant portion of the IPO proceeds—Rs 41.3 crore—is earmarked for setting up new service centres and upgrading technology hardware. Another Rs 14.4 crore is planned for lease payments at existing Indian facilities, while Rs 10.1 crore is allocated for international growth through its US subsidiary. The company also intends to spend Rs 10.2 crore on brand awareness and outreach.
While the expansion plans are clear, investors should consider the financial reality of this growth phase. The company has reported negative operating cash flow for the financial year 2026. This is common for companies in an aggressive growth phase where spending on new centres and technology precedes stable profitability. However, this structure puts pressure on the company to execute its expansion plans quickly and efficiently to reach a break-even point. The target to establish 319 new centres by the 2029 financial year is an aggressive milestone, and any delay in setting up or filling these centres could impact future financial performance.
From a valuation and comparison perspective, the company currently lacks direct, listed peers in the Indian market, which can make it difficult for investors to determine if the pricing is attractive compared to competitors. Because there are no similar listed companies for a direct side-by-side comparison, investors are relying primarily on the company's own growth narrative and the grey market sentiment. As of now, the grey market is unofficially trading at a premium of around Rs 38, which implies a potential listing gain of roughly 16 percent. However, grey market figures are speculative and unregulated, meaning they do not account for the risks inherent in the business.
The subscription window for this IPO remains open until September 3, 2026. The key monitorables for investors beyond the final subscription numbers will be the company’s ability to manage its cash flow while meeting its aggressive center-opening targets in the coming years.